首页> 外文期刊>The American Journal of Psychiatry >Toxic Effects of Depression on Brain Function: Impairment of Delayed Recall and the Cumulative Length of Depressive Disorder in a Large Sample of Depressed Outpatients
【24h】

Toxic Effects of Depression on Brain Function: Impairment of Delayed Recall and the Cumulative Length of Depressive Disorder in a Large Sample of Depressed Outpatients

机译:抑郁症对脑功能的毒性作用:大量抑郁症门诊患者的延迟回忆和抑郁障碍的累积长度受损

获取原文
获取原文并翻译 | 示例
           

摘要

An important current hypothesis suggests that the relationship between severe depression and the hippocampus is essentially toxic. The purpose of this study was to assess the generalizability of the impact of depression on hippocampal function. Participants were 8,229 outpatients who 1) fulfilled DSM-IV criteria for major depressive disorder based on clinical assessment and 2) were tested for delayed recall, a memory function that is particularly related to hippocampal integrity in humans, during two visits several weeks apart. As expected, at presentation with depression, the subjects' current illness severity was the major determinant of performance, as opposed to the intensity of their previous depressive history (the number and length of past episodes). However, following clinical response at the second visit, the length of previous depressive history became more significant than current symptoms. The following factors had significant, independent impact: age, education level, and profession. Previous studies of small samples assessed for memory function, more or less specific to the hippocampus, have shown great variability in age, gender, education level, and the length and intensity of depressive episode. Hence, a very large sample was required to disentangle the central effect of previous depressive history. As demonstrated in a general practice sample in this study, the hypothesis that the length of past depression impairs memory performance is supported, suggesting that there is a toxic link between the burden of depression and cognition. This finding has important implications for public health.
机译:当前的一个重要假设表明,严重抑郁与海马之间的关系实质上是有毒的。这项研究的目的是评估抑郁症对海马功能的影响的普遍性。参与者为8,229名门诊患者,他们1)在临床评估的基础上达到了重度抑郁症的DSM-IV标准,并且2)进行了延迟回想的测试,这种记忆功能与人类海马体的完整性特别相关,两次相隔几周。正如预期的那样,在出现抑郁症时,受试者当前的疾病严重程度是其表现的主要决定因素,而不是其先前抑郁史的强度(过去发作的次数和持续时间)。但是,在第二次就诊后出现临床反应之后,以前的抑郁史的持续时间变得比当前症状更重要。以下因素具有重大的,独立的影响:年龄,文化程度和职业。先前对记忆功能进行评估的小样本研究(或多或少对海马体具有特异性)显示,年龄,性别,受教育程度以及抑郁发作的持续时间和强度存在很大差异。因此,需要一个非常大的样本来解开先前抑郁史的中心作用。正如本研究中的一般实践样本所证明的那样,过去抑郁症的时间长短会损害记忆能力的假说得到了支持,这表明抑郁症的负担与认知之间存在毒性联系。这一发现对公共卫生具有重要意义。

著录项

  • 来源
    《The American Journal of Psychiatry》 |2008年第6期|p.731-739|共9页
  • 作者单位

    Philip Gorwood, M.D., Ph.D.Emmanuelle Corruble, M.D., Ph.D.Bruno Falissard, M.D., Ph.D.Guy M. Goodwin, D.Phil., F.Med.Sci.Received April 3, 2007, revisions received Oct. 10 and Dec. 11, 2007, accepted Jan. 17, 2008 (doi: 10.1176/appi.ajp.2008.07040574). From INSERM U675, Institut Fédératif de Recherche (IFR 02), Paris, Assistance Publique-Hôpitaux de Paris, Service de Psychiatrie Adulte, Louis Mourier Hospital (Paris 7), Colombes, France, Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Bicêtre University Hospital, Le Kremlin Bicêtre, France, INSERM U 669, Paris, University Paris-Sud and Paris Descartes, UMR-S0669, Paris, Assistance Publique-Hôpitaux de Paris, Paul Brousse Hospital, Public Health Department, Villejuif, France, and thé Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford. UK. Address correspondence and reprint requests to Dr. Gorwood, INSERM U675, Faculty of Medicine Bichat (IFR02), 16 rue Henri Huchard. 75018 Paris, France, philip.gorwood@lmr.aphp.fr (e-mail).Dr. Gorwood has received research grants from Eli Lilly, he has received speakers honoraria from Lundbeck, Servier, and UCB-Pharma, and he has served on the advisory boards for Janssen, Servier, and Wyeth. Dr. Corruble has received speakers honoraria from Servier, Eli Lilly, Wyeth, Bristol-Myers Squibb, and UCB-Pharma, and he has served on the advisory boards of Servier, Janssen, and Wyeth. Dr. Falissard has received speakers honoraria from Bristol-Myers Squibb, Servier, Pierre Fabre, and Eli Lilly, and he has served on the advisory boards of Eli Lilly. Janssen Cilag, and Sanofi-Aventis. Dr. Goodwin has received research grants from Sanofi-Aventis and Servier, he has received speakers honoraria from AstraZeneca, Bristol-Myers Squibb, Eisai, Lundbeck, Sanofi-Aventis, and Servier, and he has served on the advisory boards of AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Lundbeck. P1 Vital, Sanofi-Aventis, Servier, and Wyeth.Supported by a research grant from Servier. Servier had no involvement in the design, organization, analysis, or preparation for publication of the study.,;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号